QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 eterna-therapeutics-presents-development-of-beta-2-microglobulin-knockout-imsc-line-with-enhanced-immunosuppressive-activity-and-stealthing-features-that-may-further-augment-the-therapeutic-potential-of-mscs-in-inflammatory-diseases-at-the-asgct-annual-meeting

The presentation reports the development of a beta 2 microglobulin-knockout (B2M-KO) iMSC line with enhanced immunosuppressive ...

 eterna-therapeutics-to-present-at-the-asgct-27th-annual-meeting-on-development-of-beta-2-microglobulin-knockout-imsc-line-with-enhanced-immunosuppressive-activity-and-stealthing-features-that-may-further-augment-the-therapeutic-potential-of-mscs-in-inflammatory-diseases

The presentation reports the development of a beta 2 microglobulin-knockout (B2M-KO) iMSC line with enhanced immunosuppressive ...

 eterna-therapeutics-inc-on-march-19-received-a-notice-from-nasdaq-stating-that-co-is-not-in-compliance-with-nasdaq-listing-rule-5550b1

-SEC Filing

 eterna-therapeutics-13g-filing-shows-iaf-llc-reported-a-999-passive-stake-in-the-co-as-of-dec-14

- SEC Filing

 eterna-therapeutics-announces-92m-convertible-debt-and-warrant-financing

 Eterna Therapeutics Inc. a life science company committed to realizing the potential of mRNA cell engineering to provide patie...

 stocks-that-hit-52-week-lows-on-friday

  On Friday, 63 companies hit new 52-week lows.

 eterna-therapeutics-and-factor-bioscience-announce-new-data-on-multi-cell-type-therapeutic-approach-at-american-society-of-gene--cell-therapy-26th-annual-meeting

Approach is potentially first iPS cell-derived multi-cell-type therapeutic strategy designed to mimic how the human immune syst...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION